Other languages Virax Biolabs Group Limited

Equities

VRAX

KYG9495L1251

Market Closed - Nasdaq Other stock markets 21:30:01 03/05/2024 BST			5-day change	1st Jan Change
0.6139 ^USD	+0.64%		-11.03%	-57.95%

04-25	Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024	CI
01-12	Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024	04-25
Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2023	01-12
Virax Biolabs Group Limited Forges Strategic Research Collaboration with University of Manchester and Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients	12-21
Top Premarket Gainers	12-12
Virax Biolabs Group Names Nigel McCracken Operating Chief.	01/09/23
Virax Biolabs Group Limited Announces Management Changes	01/09/23
Virax Biolabs Group Limited Signs Contracts to Launch Two New Research and Laboratory Facilities in the United Kingdom	18/07/23
Virax Biolabs Group Limited Reports Earnings Results for the Full Year Ended March 31, 2023	14/06/23
Virax Biolabs Group Limited Auditor Raises 'Going Concern' Doubt	13/06/23
Virax Biolabs Group Limited Announces Establishment of Regional Headquarters at Dubai Science Park	04/05/23
Virax Biolabs Group Limited Enters into an Agreement for the Distribution of Marburg Virus PCR Testing Kits	19/04/23
Traders Cautious Ahead of Powell Testimony, Stifling US Equity futures	07/03/23
Virax Biolabs Signs Agreement to Distribute Avian Influenza A Virus Test Kit in the European Union; Shares Surge Pre-Bell	07/03/23
Top Premarket Gainers	07/03/23
Virax Biolabs Group Limited Enters into an Agreement for the Distribution of an Avian Influenza A Virus	07/03/23
Top Premarket Gainers	27/02/23
Cosmos Health Sets First Purchase Order for Virax Biolabs' COVID-19, Influenza Tests	07/02/23
Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health	07/02/23
Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health	07/02/23
Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2022	02/02/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Virax Biolabs Group Limited

Equities

VRAX

KYG9495L1251

Other languages

Filters